Billion-Pound Ambition Meets Market Reality: Xeinadin Sale Shelved as Bidders Balk at Price
Private equity firm Exponent has halted the auction of UK accounting group Xeinadin after potential buyers refused to meet its £1bn valuation, signaling potential headwinds for deal-making in the professional services sector.